Tipranavir
Back to searchMolecule Structure
Scientific Name
Tipranavir
Description of the Drug
Tipranavir is a protease inhibitor used to treat HIV-1 resistant to more than 1 protease inhibitor.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00932
http://www.drugbank.ca/drugs/DB00932
Brand Name(s)
Aptivus
Company Owner(s)
Boehringer Ingelheim Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL40629 | |
DrugBank | DB00932 | |
PubChem: Thomson Pharma | 14813793 | 14813794 |
PubChem | 54682461 | |
Nikkaji | J790.736B | |
PDBe | TPV | |
BindingDB | 50479982 | |
EPA CompTox Dashboard | DTXSID6048622 | |
DrugCentral | 3609 | |
Brenda | 2316 | |
ChemicalBook | CB9501005 | |
rxnorm | TIPRANAVIR | APTIVUS |
PubChem: Drugs of the Future | 12015070 | |
ChEBI | 63628 | |
ZINC | ZINC000100016058 |